Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
This article was originally published at: https://techcrunch.com/2026/07/20/colossal-biosciences-re...